 |
Actos: Takeda, Eli Lilly told to pay $9bn damagesA US jury ordered Takeda Pharmaceutical to pay $6 billion in damages over claims that it concealed cancer risks associated with its Actos diabetes drug, the plaintiffs' lawyer said on Tuesday. The massive award was met with &q More… |
 |
US delays decision on Takeda diabetes drugJapan's Takeda Pharmaceutical Company said US regulators had extended their review of its diabetes drug alogliptin, requesting additional data on what the company hopes will be the successor to its top-selling Actos drug. &n More… |
 |
Glaxo diabetes drug to stay on marketGlaxoSmithKline's diabetes pill Avandia should stay on the the market even though data suggest it may raise the risk of a heart attack for some patients, US advisers said. Most of the advisory panel said the Food and Drug Administration sh More… |
|
Glaxo diabetes drug to stay on marketGlaxoSmithKline's diabetes pill Avandia should stay on the the market even though data suggest it may raise the risk of a heart attack for some patients, US advisers said. Most of the advisory panel said the Food and Drug Administration sh More… |
